Wellness Index Report, an independent wellness ratings and education platform, has published a new Inside the Index feature recognizing Nefense as a leader in nasal health innovation. The report examines Nefense's hypochlorous acid (HOCl) and xylitol-based products, which are gaining attention as drug-free alternatives to traditional over-the-counter nasal sprays.
The feature highlights growing consumer interest in nasal health, respiratory hygiene, and drug-free options for infection control. According to Wellness Index Report, Nefense offers doctor-recommended, ENT-approved solutions suitable for families. These products are formulated under the direction of Dr. Richard Downs, DDS, and rely on HOCl's antimicrobial and anti-inflammatory properties, which emerging research supports for respiratory health applications.
Wellness Index Report was founded by Lindsay O'Neill-O'Keefe and aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. The new Inside the Index feature is part of an editorial series that spotlights companies and technologies shaping the future of wellness.
This recognition underscores the shift toward non-pharmaceutical approaches to nasal care, particularly as consumers seek safer, effective alternatives. Nefense's HOCl-based sprays offer a drug-free option that may reduce reliance on medicated sprays, which can have side effects with prolonged use. The inclusion of xylitol, a natural sugar alcohol known for its ability to disrupt bacterial biofilms, further enhances the product's appeal for daily nasal hygiene.
For more details, the full announcement is available here. The news was distributed by Reportable, Inc., a press release distribution service.
The impact of this report extends to consumers looking for safe, effective nasal care products, as well as healthcare providers seeking evidence-based recommendations. By highlighting Nefense, Wellness Index Report provides a trusted resource for navigating the growing market of nasal health solutions. This could influence purchasing decisions and encourage further innovation in drug-free respiratory hygiene.
As respiratory health becomes a priority worldwide, the recognition of Nefense as a leader in nasal health innovation signals a broader acceptance of alternative therapies. The report may also prompt other companies to invest in HOCl-based products, potentially expanding access to affordable, non-toxic options for infection control and nasal wellness.
